Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Deerfield sinks $130 million into latest academic partnership

by Rowan Walrath
January 19, 2024 | A version of this story appeared in Volume 102, Issue 2

 

The health-care investment firm Deerfield Management is teaming up with Washington University in St. Louis for its latest academic partnership. Deerfield has committed up to $130 million over 10 years toward an R&D center called VeritaScience, billed as a way for the university’s scientists to turn their research into drugs. The collaboration is part of a business strategy Deerfield has pursued since 2017: setting up academic partnerships to mine for new drug ideas. The investment firm has similar deals with the Broad Institute of MIT and Harvard, Johns Hopkins University, Dana-Farber Cancer Institute, Vanderbilt University, Columbia University, and Harvard University.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.